PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.64%
Negative revenue growth while RUN stands at 20.18%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
103.15%
Gross profit growth above 1.5x RUN's 35.23%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
81.22%
EBIT growth above 1.5x RUN's 32.66%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
82.82%
Operating income growth above 1.5x RUN's 32.66%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
79.91%
Positive net income growth while RUN is negative. John Neff might see a big relative performance advantage.
79.81%
Positive EPS growth while RUN is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
79.81%
Positive diluted EPS growth while RUN is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.07%
Share reduction more than 1.5x RUN's 1.44%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.07%
Diluted share reduction more than 1.5x RUN's 2.84%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-32.48%
Negative OCF growth while RUN is at 50.21%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-24.39%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-35.27%
Negative 10Y revenue/share CAGR while RUN stands at 160.70%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-43.94%
Negative 5Y CAGR while RUN stands at 160.70%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
9.00%
3Y revenue/share CAGR under 50% of RUN's 50.62%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-162.65%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-581.92%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-50.61%
Negative 3Y OCF/share CAGR while RUN stands at 27.65%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-307.66%
Negative 10Y net income/share CAGR while RUN is at 86.42%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-171.29%
Negative 5Y net income/share CAGR while RUN is 86.42%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-54.33%
Negative 3Y CAGR while RUN is 36.49%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-103.20%
Negative equity/share CAGR over 10 years while RUN stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-104.46%
Negative 5Y equity/share growth while RUN is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-103.54%
Negative 3Y equity/share growth while RUN is at 4.49%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.46%
Our AR growth while RUN is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
3.93%
Inventory shrinking or stable vs. RUN's 18.05%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
1.83%
Asset growth well under 50% of RUN's 5.44%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-64.84%
We have a declining book value while RUN shows 0.46%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
48.51%
Debt growth far above RUN's 9.15%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-49.89%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
17.32%
SG&A growth well above RUN's 7.90%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.